{
  "ticker": "LLY",
  "target_date": "2025-11-26",
  "actual_date": "2025-11-26",
  "collected_at": "2025-12-08T12:35:03.543424",
  "price": {
    "open": 1102.0,
    "high": 1111.99,
    "low": 1098.1,
    "close": 1104.3399658203125,
    "volume": 3093700,
    "change_1d_pct": -0.5,
    "change_7d_pct": 8.09,
    "change_30d_pct": 33.8
  },
  "technicals": {
    "rsi_14": 87.34,
    "sma_20": 989.66,
    "sma_50": 875.24,
    "macd": 65.979,
    "macd_signal": 58.868,
    "macd_histogram": 7.111,
    "bb_upper": 1146.68,
    "bb_lower": 832.64,
    "price_vs_sma20_pct": 11.59,
    "price_vs_sma50_pct": 26.18,
    "volume_ratio": 0.65
  },
  "fundamentals": {
    "market_cap": 891759362048,
    "pe_ratio": 48.738853,
    "forward_pe": 43.899384,
    "price_to_book": 37.453316,
    "price_to_sales": 15.007781,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.54,
    "pct_from_52w_low": 59.47
  },
  "macro": {
    "spy": {
      "price": 679.68,
      "change_1d_pct": 0.69,
      "change_7d_pct": 2.97
    },
    "vix": {
      "level": 17.19,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.0
    },
    "dollar_index": {
      "level": 99.6
    },
    "gold": {
      "price": 4165.2
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Why Eli Lilly (LLY) Hit $1 Trillion as Obesity Drug Momentum Ignites Investor Optimism",
      "source": "Yahoo",
      "datetime": 1764194931,
      "summary": "Eli Lilly recently became the first healthcare company to surpass a $1 trillion market capitalization, propelled by surging demand for its GLP-1-based diabetes and obesity drugs, Zepbound and Mounjaro, alongside significant pipeline developments and expanded Medicare and Medicaid coverage. This mile",
      "url": "https://finnhub.io/api/news?id=b244e7017947bfa828ca6be5a23ec797818294293a036905e9e23bf8e83c56ca"
    },
    {
      "headline": "Hard for Eli Lilly to move significantly higher from here in the short-term: Kessef Capital's Yaffee",
      "source": "CNBC",
      "datetime": 1764180201,
      "summary": "Len Yaffee, Kessef Capital, join 'Fast Money' to talk Amgen's obesity drug, Eli Lilly's current stock action, and much more.",
      "url": "https://finnhub.io/api/news?id=303b5ffda98d091833cda4518ed68b709c9b7ee68ad5481c0cbe374568362820"
    },
    {
      "headline": "CMS Slashes Prices Of 15 Major Drugs - Here's Why Pharma Valuations Won't Suffer",
      "source": "SeekingAlpha",
      "datetime": 1764176336,
      "summary": "Discover how new U.S. Medicare drug price cuts impact major pharma stocks like Novo Nordisk and why sector resilience supports a strong outlook. Click for more.",
      "url": "https://finnhub.io/api/news?id=1f6a4babd9bee8ff46ea9bfd57aa2d2c9e4fb232cd4ea10363ae33b37483d4b4"
    },
    {
      "headline": "Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026",
      "source": "Yahoo",
      "datetime": 1764174840,
      "summary": "Eli Lilly's stock is surging amid a flurry of AI deals. Our proprietary Zacks Rank system confirms the trend.",
      "url": "https://finnhub.io/api/news?id=17fee0e918b3b6d0041c32c128613a1763c9af7e00c40d9e2bda6ffa0c7f9870"
    },
    {
      "headline": "CURE: Analysts Strike A Cautious Tone Heading Into 2026",
      "source": "SeekingAlpha",
      "datetime": 1764174517,
      "summary": "Discover why the Direxion Healthcare Bull 3X ETF is outperforming in 2025. Learn about key risks, returns, and buy ratings.",
      "url": "https://finnhub.io/api/news?id=a5ef5754831c30f25c83c66be5e038c5194b41554790fb800b0ad9b7a81a6a4b"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041104.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000093/xslF345X05/form4-11262025_041104.xml"
    },
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000092/xslF345X05/form4-11262025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-25",
      "description": "xslF345X05/form4-11252025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000089/xslF345X05/form4-11252025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-24",
      "description": "xslF345X05/form4-11242025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000087/xslF345X05/form4-11242025_041101.xml"
    },
    {
      "form": "8-K",
      "date": "2025-11-21",
      "description": "lly-20251118.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/lly-20251118.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}